This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Dose

Authoring team

The initial dose is 3-4mg/kg daily or 150-300mg daily. This may be in a single dose or divided into two doses. The dose is increased gradually as required (table below).

  • adult daily dose 200-500 mg
  • serum half-life 24-48 hours
  • dose frequency x/day 2

Because the plasma half-life is long (24-48 hrs) phenytoin needs to be given only twice or even once daily. When oral administration is not possible, the drug can be given intravenously (eg 100 to 250 mg at <= 50 mg/minute in an adult). For comprehensive details on the use of this drug, see BNF 4.8.1.

The parenteral preparation is strongly alkaline and may crystallise out in tissues; the intramuscular route is therefore painful and associated with unreliable absorption. Daily doses over 300 to 350 mg should be exceeded only cautiously and with frequent monitoring of serum levels. Increments in the daily dose should not exceed 25-50 mg at this level.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.